Ah – the holidays – a time of good cheer, getting together with friends and family and wading through a bountiful bonanza of tantalizing foods that can make your buttons burst just by thinking about them for too long. The holidays – which for all practical purposes now stretch from the end of October through the beginning of January – are often a time of strife for those trying to maintain or lose weight. (more…)
When most people think of neurotransmitter imbalances, they think of disorders such as depression, anxiety, insomnia and possibly ADD/ADHD and Parkinson’s disease. Usually, that’s because the drugs used to treat these disorders attempt to manipulate various neurotransmitters – including serotonin, dopamine, norepinephrine and GABA – in order to help alleviate symptoms. (more…)
Parkinson’s disease is classified as a progressive neurodegenerative disease that affects more than ten million people worldwide, with approximately 60,000 new cases diagnosed each year. The most effective treatment for Parkinson’s disease is L-dopa; however, many people that take L-dopa experience extreme nausea which prevents them from taking enough L-dopa to achieve a relief of symptoms. In May of 1975, the FDA approved the drug carbidopa to manage L-dopa induced nausea, and the drug Sinemet® (carbidopa/L-dopa) was approved. (more…)
Since introducing the idea of dopamine dominance, I have received several questions about the difference between dopamine dominance and the dopamine challenge. This post will attempt to clarify these two important points. (more…)
There has been a recent breakthrough in the use of amino acid therapy based on the work of Marty Hinz, MD. The work of Dr. Hinz and his associates can provide a key piece of information for people that are not finding relief from symptoms related to neurotransmitter dysfunction using the typical Three Phase Model approach. Based on the research of Dr. Hinz, this represents about 6-8% of people using amino acid therapy under the guidance of a trained health care professional. (more…)
In a previous post, we addressed the question: “do allergies cause neurotransmitter imbalance?” In addressing that question, I eluded to the fact that although allergies do not necessarily cause neurotransmitter imbalance, excessive histamine release (due to allergies) could theoretically cause neurotransmitter imbalances over time, which could lead to any number of symptoms. Conversely, we have found a link between allergies and neurotransmitter balance: that increasing dopamine levels can have a powerful antihistamine effect, substantially decreasing seasonal allergies. (more…)
Give the gift of health!
